Dividend Information about National Health: Everything You Need to Know Before Its Ex-Dividend Date on Sep 30, 2025
Generado por agente de IAAinvest Dividend Digest
viernes, 26 de septiembre de 2025, 8:12 pm ET1 min de lectura
NHI--
National Health (NHI) has announced a cash dividend of $0.92000000 per share, with an ex-dividend date set for Sep 30, 2025, and a payment date of Oct 31, 2025. The dividend was officially declared on Aug 6, 2025, the same day the company also announced its second-quarter 2025 earnings and an investor update. This upcoming payout is higher than the average of the last 10 dividend amounts, which stands at $0.662051724137931, signaling a potentially stronger financial outlook for the real estate investment trust. The company last paid a cash dividend of $0.90000000 per share on Aug 1, 2025, marking a modest increase in its dividend per share for this latest offering.
Over the past week, National HealthNHI-- Investors has been making headlines with several strategic moves that could influence its market performance. On Sep 22, 2025, the company announced the successful pricing of a $350 million offering of senior unsecured notes, a move analysts suggest could indicate a shift in its capital strategy to support long-term growth. Around the same time, the company’s stock was highlighted as an outperformer by AI-driven analysts, citing strong financial fundamentals and positive technical indicators. Additionally, insider trading activity was reported on Sep 25, 2025, with three insider trades recorded in a single day, which may suggest confidence in the company’s future direction.
Since the last update, National Health Investors has demonstrated a robust financial position, maintaining its role as a key player in the healthcare real estate sector through sale-leaseback and joint-venture arrangements. The recent issuance of unsecured notes is expected to provide the company with greater flexibility to expand its investment portfolio and strengthen its balance sheet. With its latest dividend announcement, NHINHI-- continues to reinforce its commitment to shareholder returns, particularly as it navigates a competitive and evolving industry landscape.
Investors should be aware that the ex-dividend date for this upcoming payout is Sep 30, 2025, meaning that any purchase of NHI stock after this date will not qualify for the dividend. As the company continues to execute on its growth strategy and deliver consistent returns, it remains a key name to watch in the healthcare real estate investment space.
National Health (NHI) has announced a cash dividend of $0.92000000 per share, with an ex-dividend date set for Sep 30, 2025, and a payment date of Oct 31, 2025. The dividend was officially declared on Aug 6, 2025, the same day the company also announced its second-quarter 2025 earnings and an investor update. This upcoming payout is higher than the average of the last 10 dividend amounts, which stands at $0.662051724137931, signaling a potentially stronger financial outlook for the real estate investment trust. The company last paid a cash dividend of $0.90000000 per share on Aug 1, 2025, marking a modest increase in its dividend per share for this latest offering.
Over the past week, National HealthNHI-- Investors has been making headlines with several strategic moves that could influence its market performance. On Sep 22, 2025, the company announced the successful pricing of a $350 million offering of senior unsecured notes, a move analysts suggest could indicate a shift in its capital strategy to support long-term growth. Around the same time, the company’s stock was highlighted as an outperformer by AI-driven analysts, citing strong financial fundamentals and positive technical indicators. Additionally, insider trading activity was reported on Sep 25, 2025, with three insider trades recorded in a single day, which may suggest confidence in the company’s future direction.
Since the last update, National Health Investors has demonstrated a robust financial position, maintaining its role as a key player in the healthcare real estate sector through sale-leaseback and joint-venture arrangements. The recent issuance of unsecured notes is expected to provide the company with greater flexibility to expand its investment portfolio and strengthen its balance sheet. With its latest dividend announcement, NHINHI-- continues to reinforce its commitment to shareholder returns, particularly as it navigates a competitive and evolving industry landscape.
Investors should be aware that the ex-dividend date for this upcoming payout is Sep 30, 2025, meaning that any purchase of NHI stock after this date will not qualify for the dividend. As the company continues to execute on its growth strategy and deliver consistent returns, it remains a key name to watch in the healthcare real estate investment space.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios